Worldwide Report - ADHD Drugs Market 2014-2018

Global ADHD Drugs Market 2014-2018 is the latest addition to industry research reports collection.

ADHD is a psychiatric disorder, which is mostly found in children. However, adults have also been reported to be diagnosed with ADHD. The patients with ADHD suffer from several problems including hyperactivity, impulsiveness, and lack of focus and concentration. The causes of ADHD are not known. It is believed to be linked with genetic and environmental causes. However, it has been reported to be related with the decrease in the extraneuronal levels of norepinephrine and dopamine. In addition, the patients have an abnormality in the brain structure. It is more prevalent in boys than girls. The management of ADHD is done by counseling, medications, and lifestyle changes.

Analysts forecast the Global ADHD Drugs market to grow at a CAGR of 5.33 percent over the period 2013-2018.

Single User License of the report is Available at US $2500

TechNavio recognizes the following companies as the key players in the Global ADHD Drugs Market: Eli Lilly and Co., Janssen Pharmaceuticals Inc., Novartis AG and Shire plc.

Other Prominent Vendors in the market are: Actavis, Alcobra, Amarantus, Boehringer Ingelheim, Concordia, Curemark, GlaxoSmithKline, Hisamitsu, Impax, Intellipharmaceutics, Mylan, Neurovance, Noven, Par Pharmaceuticals, Sanofi, Shionogi, Sunovion, Teva and Tris Pharma

One key trend emerging in this market is an increase in awareness, which is helping to increase the number of treatment-seeking patients.

Order a copy of this report at (Prices start at US $2500 for a single user PDF) .

Covered in this Report

This report covers the present scenario and the growth prospects of the Global ADHD Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of ADHD, which include:
• Stimulants
• Non-stimulants

Global ADHD Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global ADHD Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, the major driving factor in this market is the high unmet need for appropriate drugs in the market. The current treatment options cannot cure the disorder completely, and thus market demand is high for this indication. Therefore, drugs that can cause disease remission in patients are expected to drive the market significantly.

Further, the report states that the unknown etiology of the disease is a major factor that restricts the growth of the market. This makes it difficult for drug makers to identify a target that can be used to develop a medication to cure ADHD.

Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Market Landscape
08. Market Segmentation by Product Type
09. Market Segmentation by Route of Administration
10. Market Segmentation by Dosage Form
11. Geographical Segmentation
12. Key Leading Countries
13. Rate of Incidence and Prevalence
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape22. Pipeline Portfolio
23. Key Vendor Analysis
24. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global ADHD Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global ADHD Drugs Market by Product Type
Exhibit 4: Global ADHD Drugs Market Segmentation by Product Type 2013
Exhibit 5: Global ADHD Drugs Market by Route of Administration
Exhibit 6: Global ADHD Drugs Market Segmentation by Route of Administration 2013
Exhibit 7: Global ADHD Drugs Market by Dosage Form
Exhibit 8: Global ADHD Drugs Market Segmentation by Dosage Form 2013
Exhibit 9: Global ADHD Drugs Market by Geographical Segmentation 2013
Exhibit 10: ADHD Drugs Market in Americas 2013-2018 (US$ million)
View all 38 Exhibits

Have any Query on the Report get your Queries Resolved at .

About US: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.